MedTrace Logo

Type 1 Diabetes Recurrence in Pancreas Transplants

NCT01047865 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 400

Last updated 2025-01-16

No results posted yet for this study

Summary

The hypothesis is that humoral and cellular islet-specific responses are an early risk factor for recurrence of autoimmunity and hyperglycemia in simultaneous pancreas-kidney (SPK) recipients independent of alloimmunity. This study will test the hypothesis and will assess their individual and combined predictive value.

Conditions

  • Diabetes Mellitus, Type 1

Sponsors & Collaborators

  • University of Miami

    lead OTHER

Principal Investigators

  • George Burke, M.D. · University of Miami

Eligibility

Min Age
18 Years
Max Age
75 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2005-05-31
Primary Completion
2026-05-31
Completion
2026-05-31

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01047865 on ClinicalTrials.gov